| Trial ID: | L1073 |
| Source ID: | NCT02596945
|
| Associated Drug: |
Methoxy Polyethylene Glycol Epoetin Beta
|
| Title: |
Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02596945/results
|
| Conditions: |
Renal Impairment|Renal Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Methoxy polyethylene glycol epoetin beta
|
| Outcome Measures: |
Primary: Percentage of Participants With Hemoglobin Values in the Range of 11-12 Grams Per Deciliter (g/dL) During the Evaluation Period of Visit 7 (Month 7) to Visit 9 (Month 9), Month 7 to Month 9 | Secondary: Percentage of Participants With Hemoglobin Values in the Range of 11-13 g/dL During the Evaluation Period of Visit 7 (Month 7) to Visit 9 (Month 9), Month 7 to Month 9|Average Duration in Days Mircera Was Administered at a Stable Dose, Up to 9 months
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
223
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-07-31
|
| Completion Date: |
2011-02-28
|
| Results First Posted: |
2016-01-13
|
| Last Update Posted: |
2017-07-02
|
| Locations: |
Dres. Michael Koch Hannelore Klimke Wolfgang Kulas u.w., Mettmann, 40822, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT02596945
|
